Jilin University Zhengyuan Information Technologies Co.Ltd(003029)
Prior approval opinions of independent directors on daily connected transactions expected in 2022
Jilin University Zhengyuan Information Technologies Co.Ltd(003029) (hereinafter referred to as “the company”) the proposal on daily connected transactions in 2022 to be considered at the 11th meeting of the 8th board of directors has been submitted to us for review before the meeting, In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the rules for independent directors of listed companies, the stock listing rules of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, the Jilin University Zhengyuan Information Technologies Co.Ltd(003029) articles of association and other relevant provisions, we are independent directors of the company, With a serious and responsible attitude, we have carefully reviewed the above proposals and checked the relevant conditions in detail. Based on our independent judgment, we hereby express the following opinions on the above proposals:
According to the relevant provisions of the Listing Rules of Shenzhen Stock Exchange and in combination with the actual situation of the company, we agree that the daily related party transactions to be considered at this meeting are normal business activities, the pricing is fair and reasonable, and there is no transfer of interests and damage to the interests of shareholders, especially the interests of minority shareholders, We unanimously agreed to submit the proposal to the 11th meeting of the 8th board of directors of the company for deliberation.
(there is no text on this page, which is the signature page of Jilin University Zhengyuan Information Technologies Co.Ltd(003029) independent directors’ prior approval opinions on matters related to the 11th meeting of the 8th board of directors) signature of independent directors:
Wang Jinyong, Liu Xiuwen, Zhao Guohua
